Blinatumomab, a new drug for childhood leukemia, has been a game-changer for young patients, allowing them to live more ...
Researchers from the Alliance for Clinical Trials in Oncology have found that two targeted immunotherapy drugs lead to high ...
Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...
The FDA has issued a complete response letter (CRL) to a new drug application (NDA) for Dasynoc for the treatment of chronic ...
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial Studying 767 children ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...
As Suleika Jaouad faces leukemia for the third time in 15 years, she is sharing her story with CURE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback